Mahima Lall1, Sourav Sen2, Seema Patrikar3, Santosh Karade4, R M Gupta5. 1. Associate Professor, Department of Microbiology, Armed Forces Medical College, Pune, India. 2. Professor & Head, Department of Microbiology, Armed Forces Medical College, Pune, India. 3. Lecturer in Statistics & Demography, Department of Community Medicine, Armed Forces Medical College, Pune, India. 4. Assistant Professor, Department of Microbiology, Armed Forces Medical College, Pune, India. 5. Dean & Dy Commandant, Armed Forces Medical College, Pune, India.
Abstract
Background: Hepatitis B (HepB) is an important vaccine preventable infection among healthcare workers (HCWs). Vaccination against Hep B virus, remains the foremost preventive approach. This study aims to measure the antibody titres to Hep B surface antigen (anti-HBs) in a mixed cohort of HCWs. It also aims to study the association between time since vaccination and the anti-HBs titres thus evaluating the duration of seroprotection. Methods: A total of 200 HCWs, including nursing students (n = 112), nursing staff (n = 49), laboratory technicians (n = 30) and doctors (n = 9) who had received all three doses of the Hep B vaccine and met the inclusion criteria of having taken all three doses of vaccine were included in this study. Anti-HBs titres were estimated by bioMérieux mini VIDAS® automated immunoassay based on the principle of enzyme-linked fluorescence assay. Results: Two hundred subjects aged 19 to 52 years were included in the study; mean age was 27.29 ± 0.568 years. Duration since vaccination in the study cohort was ≤ 5 years in 149 (74.5.0%), 6-10 years in 20 (10.0%) and >10 years in 31 (15.5%) subjects. Postvaccination antibody titres were > 100 mIU/ml in 85.0%, 10-100 mIU/ml in 11.0% and ≤ 10 mIU/ml in 3.5%. There was a decline noted in antibody titres as duration after vaccination increased. Increasing age was associated with falling protective titres. Conclusion: The study revealed that majority of the HCWs had adequate anti-HBs titres and were protected after vaccination.
Background: Hepatitis B (HepB) is an important vaccine preventable infection among healthcare workers (HCWs). Vaccination against Hep B virus, remains the foremost preventive approach. This study aims to measure the antibody titres to Hep B surface antigen (anti-HBs) in a mixed cohort of HCWs. It also aims to study the association between time since vaccination and the anti-HBs titres thus evaluating the duration of seroprotection. Methods: A total of 200 HCWs, including nursing students (n = 112), nursing staff (n = 49), laboratory technicians (n = 30) and doctors (n = 9) who had received all three doses of the Hep B vaccine and met the inclusion criteria of having taken all three doses of vaccine were included in this study. Anti-HBs titres were estimated by bioMérieux mini VIDAS® automated immunoassay based on the principle of enzyme-linked fluorescence assay. Results: Two hundred subjects aged 19 to 52 years were included in the study; mean age was 27.29 ± 0.568 years. Duration since vaccination in the study cohort was ≤ 5 years in 149 (74.5.0%), 6-10 years in 20 (10.0%) and >10 years in 31 (15.5%) subjects. Postvaccination antibody titres were > 100 mIU/ml in 85.0%, 10-100 mIU/ml in 11.0% and ≤ 10 mIU/ml in 3.5%. There was a decline noted in antibody titres as duration after vaccination increased. Increasing age was associated with falling protective titres. Conclusion: The study revealed that majority of the HCWs had adequate anti-HBs titres and were protected after vaccination.
Authors: Naveen Gara; Adil Abdalla; Elenita Rivera; Xiongce Zhao; Jens M Werner; T Jake Liang; Jay H Hoofnagle; Barbara Rehermann; Marc G Ghany Journal: Clin Infect Dis Date: 2014-11-10 Impact factor: 9.079
Authors: A Mehta; C Rodrigues; T Singhal; N Lopes; N D'Souza; K Sathe; F D Dastur Journal: Indian J Med Microbiol Date: 2010 Jan-Mar Impact factor: 0.985
Authors: Stephanie Popping; Debora Bade; Charles Boucher; Mark van der Valk; Manal El-Sayed; Olafsson Sigurour; Vana Sypsa; Timothy Morgan; Amiran Gamkrelidze; Constance Mukabatsinda; Sylvie Deuffic-Burban; Michael Ninburg; Jordan Feld; Margaret Hellard; John Ward Journal: J Virus Erad Date: 2019-01-01
Authors: F C van der Scheun; M C M Nagelkerke; A Kilaru; V Shridhar; R Prasad; T S van der Werf Journal: BMC Health Serv Res Date: 2019-10-22 Impact factor: 2.655